{"id":"etallobarbital","rwe":[],"tags":[{"label":"etallobarbital","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"N05CA20","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ethallymal","offLabel":[],"synonyms":["etallobarbital","ethallobarbital","ethallymal","aethallymal"],"timeline":[],"approvals":[],"brandName":"Ethallymal","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"etallobarbital","explanation":"Imagine your brain is like a busy city with lots of people talking and moving around. GABA is like a traffic cop that helps to slow down the traffic and keep everything calm. Etallobarbital helps GABA do its job more effectively, which can lead to feelings of relaxation and reduced anxiety.","oneSentence":"Etallobarbital works by enhancing the activity of a neurotransmitter called gamma-aminobutyric acid (GABA), which helps to calm the brain and nervous system.","technicalDetail":"Etallobarbital is a barbiturate that acts as a positive allosteric modulator of the GABA_A receptor, enhancing the activity of GABA and leading to increased chloride ion influx into neurons, resulting in hyperpolarization and decreased neuronal excitability."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4743","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=etallobarbital","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:05:18.077849","biosimilars":[],"competitors":[{"drugName":"pentobarbital","drugSlug":"pentobarbital","fdaApproval":"1973-09-19","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"amobarbital","drugSlug":"amobarbital","fdaApproval":"","relationship":"same-class"},{"drugName":"secobarbital","drugSlug":"secobarbital","fdaApproval":"1950-07-19","genericCount":19,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"talbutal","drugSlug":"talbutal","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"methohexital","drugSlug":"methohexital","fdaApproval":"1960-06-27","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"thiopental","drugSlug":"thiopental","fdaApproval":"","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"etallobarbital","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"pentobarbital","brandName":"pentobarbital","genericName":"pentobarbital","approvalYear":"1973","relationship":"same-class"},{"drugId":"amobarbital","brandName":"amobarbital","genericName":"amobarbital","approvalYear":"","relationship":"same-class"},{"drugId":"secobarbital","brandName":"secobarbital","genericName":"secobarbital","approvalYear":"1950","relationship":"same-class"},{"drugId":"talbutal","brandName":"talbutal","genericName":"talbutal","approvalYear":"","relationship":"same-class"},{"drugId":"methohexital","brandName":"methohexital","genericName":"methohexital","approvalYear":"1960","relationship":"same-class"},{"drugId":"thiopental","brandName":"thiopental","genericName":"thiopental","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"6F1R68CB4I","CHEBI":"CHEBI:136028","UMLSCUI":"C3652697","ChEMBL_ID":"CHEMBL1988479","PUBCHEM_CID":"48542"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Neuroscience"],"atcClassification":{"source":"DrugCentral","atcCode":"N05CA20","allCodes":["N05CA20"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Etallobarbital is a small molecule barbiturate with unknown target and pharmacological properties. Its commercial status is unclear, and it is not FDA-approved for any indications. As a barbiturate, etallobarbital is a central nervous system depressant, but its specific mechanism of action and safety profile are not well-documented. Further research is needed to fully understand its therapeutic potential and risks. Due to the lack of information, etallobarbital is not a widely recognized or used medication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}